2022-11-01
Our company has been selected for the "U.S. Life Science Market Development Support Program 2022" sponsored by the Yokohama City
Our company has been selected for the "U.S. Life Science Market Development Support Program 2022" sponsored by the Yokohama City Americas Office. With the support of our program partner, Kievit Scientific, we will begin preparation to enter U.S. market. https://kievitsci.com/
2024-11-11
Yoji Jokura will present at ”The 62nd Annual Meeting of the Japanese Society for Artificial Organs”
2024-10-15
CTBE has been selected as a coworking member of the Japan Innovation Campus in Silicon Valley, USA.
2024-08-29
CTBE announces start of clinical trial for regenerative ligament for ACL reconstruction using decellularization technology
2024-07-30
Japanese medtech startup, CoreTissue BioEngineering, becomes first company accepted into accelerator program backed by Mitsubishi Corporation (Americas) and Fogarty Innovation
2023-11-15
Kiyotaka Iwasaki will be on stage as a speaker at the 1st Japanese Knee Society Conference, held on December 8th, 2023